• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Effect of Cranberry Extract on Bacteriuria in Dogs with Intervertebral Disk Herniation

January 9, 2017
Laurie Anne Walden, DVM, ELS

Researchers found recently that cranberry extract does not reduce the incidence of bacteriuria in dogs with acute intervertebral disk herniation.

In a clinical trial, cranberry extract did not reduce the incidence of bacteriuria in dogs with acute thoracolumbar disk herniation. Urine antiadhesion activity, which was not affected by cranberry supplementation, was associated with a reduced risk of Escherichia coli bacteriuria. The results of the study were recently published in the Journal of Veterinary Internal Medicine.

Researchers from North Carolina State University tested a commercial canine cranberry extract supplement (Crananidin, Nutramax Laboratories) in client-owned dogs with acute-onset nonambulatory paraparesis or paraplegia caused by thoracolumbar disk herniation. Dogs included in the study underwent surgical spinal decompression and had no signs of bacteriuria on presentation. Dogs with a history of recurrent urinary tract infection or disease that could increase the risk of urinary tract infection (such as diabetes mellitus or hyperadrenocorticism) were excluded.

Of the 94 dogs included in the final analysis, 42 were given cranberry extract according to the manufacturer’s label instructions and 52 received placebo. Treatment began 48 hours after surgery and continued for 6 weeks. Dogs were evaluated at 2, 4, and 6 weeks postoperatively. The original study design called for more patients, but the investigators closed enrollment early because an interim data analysis showed no significant treatment effect for cranberry extract.

Advertisement

The overall incidence of bacteriuria was 18% (17 positive urine cultures in 94 dogs). Eleven of the positive cultures were from dogs in the cranberry group and 6 were from dogs in the placebo group, a difference that was not significant. Female sex was the most significant risk factor for bacteriuria. Involuntary urination was also a risk factor, although its association with bacteriuria was not as strong as female sex. Catheterization, crystalluria, initial neurologic status, and neurologic grade were not significant risk factors for bacteriuria.

Because cranberry extract specifically targets Escherichia coli (proanthocyanidins in cranberries inhibit the adhesion of fimbriated bacteria—like some E. coli—to uroepithelial cells in vitro), the investigators compared the incidence of this bacterium between groups. Of the 17 positive cultures, 7 were identified as E. coli: 6 in the cranberry group and 1 in the placebo group.

The researchers also assessed urine antiadhesion activity in a subset of 47 samples. Thirty of the samples had positive antiadhesion activity, with no significant difference between the cranberry and placebo groups. The incidence of E. coli bacteriuria was significantly lower in dogs with positive urine antiadhesion activity. The clinical relevance of the urine antiadhesion activity test has not yet been established in dogs, say the authors, and they recommend further study of its relationship with E. coli bacteriuria.

The lack of difference in antiadhesion activity between the two groups could have been caused by poor compliance, poor bioavailability, or an inappropriate dose rate, write the authors. Dog owners administered the treatments at home, so compliance could not be confirmed. The dose by weight and once-daily dosing schedule of the cranberry supplement could also have been inadequate, they say.

The authors conclude that the trial did not show a benefit of cranberry supplementation in a population of dogs predisposed to bacteriuria. Because the results did indicate an association between urine antiadhesion activity and E. coli bacteriuria, they recommend further investigation of dose rates, frequency, and timing of proanthocyanidin supplementation in dogs.

Dr. Laurie Anne Walden received her doctorate in veterinary medicine from North Carolina State University. After an internship in small animal medicine and surgery at Auburn University, she returned to North Carolina, where she has been in small animal primary care practice for over 20 years. Dr. Walden is also a board-certified editor in the life sciences and owner of Walden Medical Writing, LLC. She works as a full-time freelance medical writer and editor and continues to see patients a few days each month.


Advertisement

Latest News

New technology and products for veterinary genealogy

Reduce your veterinary teams’ stress with financial wellness

Cuban crocodiles receive surgery to extract foreign items

Purina Pro Plan Veterinary Diets joins forces with AVMF

View More Latest News
Advertisement